Suppr超能文献

迷迭香叶水醇提取物对实验性脑卒中脑缺血耐受性的神经保护作用

The Neuroprotective Effect of Rosemary ( L.) Hydro-alcoholic Extract on Cerebral Ischemic Tolerance in Experimental Stroke.

作者信息

Seyedemadi Parisa, Rahnema Mehdi, Bigdeli Mohammad Reza, Oryan Shahrebano, Rafati Hassan

机构信息

Department of Physiology, Faculty of Biological Sciences, Kharazmi University, Tehran, Iran.

Department of Physiology, Islamic Azad University - Zanjan Branch, Zanjan, Iran.

出版信息

Iran J Pharm Res. 2016 Fall;15(4):875-883.

Abstract

The prevention of BBB breakdown and the subsequent vasogenic edema are important parts of the medical management of ischemic stroke. The purpose of this study was to investigate the ischemic tolerance effect of leaf hydro-alcoholic extract (RHE). Five groups of animals were designed: sham (underwent surgery without MCAO) and MCAO groups, the MCAO groups were pretreated orally by gavages with RHE (50, 75, and 100 mg/Kg/day), daily for 30 days. Two hours after the last dose, serum lipid levels were determined and then the rats were subjected to 60 min of middle cerebral artery occlusion followed by 24 h of reperfusion. Subsequently, brain infarct size, brain edema and Evans Blue dye extravasations were measured and neurological deficits were scored. Dietary RHE could significantly reduce cortical and sub-cortical infarct volumes (211.55 ± 24.88 mm. 40.59 ± 10.04 mm. 29.96 ± 12.19 mm. 6.58 ± 3.2 mm), neurologic deficit scores, cerebral edema (82.34 ± 0.42% . 79.92 ± 0.49% . 79.45 ± 0.26% vs. 79.30 ± 0.19%), blood-brain barrier (BBB) permeability (7.73 ± 0.4 μg/g tissue . 4.1 ± 0.23 μg/g tissue . 3.58 ± 0.3 μg/g tissue . 3.38 ± 0.25 μg/g tissue) in doses of 50, 75 and 100 mg/Kg/day as compared with the control group in the transient model of focal cerebral ischemia. Although pretreatment with RHE plays an important role in the generation of tolerance against cerebral I/R injury, further studies are needed to clarify the mechanism of the ischemic tolerance.

摘要

预防血脑屏障破坏及随后的血管源性水肿是缺血性中风医学治疗的重要组成部分。本研究的目的是探讨叶水醇提取物(RHE)的缺血耐受作用。设计了五组动物:假手术组(接受手术但未进行大脑中动脉闭塞术)和大脑中动脉闭塞术组,大脑中动脉闭塞术组通过灌胃每日口服RHE(50、75和100毫克/千克/天),持续30天。最后一次给药两小时后,测定血清脂质水平,然后对大鼠进行60分钟的大脑中动脉闭塞,随后再灌注24小时。随后,测量脑梗死体积、脑水肿和伊文思蓝染料外渗情况,并对神经功能缺损进行评分。在局灶性脑缺血的短暂模型中,与对照组相比,每日口服50、75和100毫克/千克/天剂量的RHE可显著减少皮质和皮质下梗死体积(分别为211.55±24.88立方毫米、40.59±10.04立方毫米、29.96±12.19立方毫米、6.58±3.2立方毫米)、神经功能缺损评分、脑水肿(分别为82.34±0.42%、79.92±0.49%、79.45±0.26%对79.30±0.19%)、血脑屏障(BBB)通透性(分别为7.73±0.4微克/克组织、4.1±0.23微克/克组织、3.58±0.3微克/克组织、3.38±0.25微克/克组织)。尽管RHE预处理在对脑缺血/再灌注损伤的耐受产生中起重要作用,但仍需要进一步研究来阐明缺血耐受的机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a9c/5316267/f0cea6f35633/ijpr-15-875-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验